Significance of Low-Level Viremia Indication in HIV
JUN 07, 2019 | PANELISTS:JOSEPH ERON, MD; PAUL SAX, MD; W. DAVID HARDY, MD; ERIC S. DAAR, MD; IAN FRANK, MD
Segment Description: Joseph Eron, MD; Paul Sax, MD; W. David Hardy, MD; Eric S. Daar, MD; Ian Frank, MD, consider the significance of low-level viremia indication.
Joseph Eron, MD: Let’s spend maybe just a couple of minutes talking about low-level viremia, which is a topic that I hate.
Paul Sax, MD: But you’ve made it sound so exciting.
Joseph Eron, MD: A topic that I hate.
Paul Sax, MD: I’ll tell you how you’re supposed to do that. It’s a fascinating topic.
W. David Hardy, MD: Let’s do it more.
Joseph Eron, MD: Ian, you introduced it. We have to be succinct, though, because we do want to talk about new drugs.
Ian Frank, MD: I have a handful—or maybe a couple of handfuls—of patients who, at every viral load determination, have a viral load that is measurable between generally 20 and 100 copies/mL. I have gotten archive-resistance tests, resistance tests on DNA—so not on the virus in plasma, which has shown wild-type virus. And we know that there are data that show that these individuals with viral loads of less than 200 copies/mL are not failing on therapy, that this is probably a virus that’s being released from a latent reservoir, not perpetuating ongoing infection, because the antiretrovirals are preventing infection of uninfected cells. Nonetheless, it just makes me nervous to see this at every visit.
Paul Sax, MD: Even though it makes us all nervous, 1 somewhat reassuring thing is that the studies of treatment as prevention all used thresholds higher than 200 copies/mL as their cutoff for virological control.
There has never been a case report of someone transmitting who has a viral load of 97 copies/mL, for example. So I think we can at least share that with patients. But it does bother them. One of my former colleagues, he actually used to order the bDNA [branched DNA] test solely to get rid of these low-level detectable viruses. It was less sensitive. I just assume order a more accurate, more reliable test.
Joseph Eron, MD: And I think that probably, for a lot of the people listening, don’t make any decision on a single test, which Eric said. Low-level viremia between 50 and 200 copies/mL is a complicated topic, and you would certainly repeat those values. Sometimes it’s just the lab, right?
Eric S. Daar, MD: Yeah.
Joseph Eron, MD: You could take the same sample and get those values. I think most of us think about switching therapy with reproducible viral loads greater than 200 copies/mL. Is that safe to say?
W. David Hardy, MD: Good point.
Paul Sax, MD: And no intensification. Note, do not intensify. Don’t add drugs to these regimens.
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512